"The US Food and Drug Administration (FDA) has approved Akorn Inc's phenylephrine hydrochloride ophthalmic solution (2.5% and 10%), the company has announced.
The alpha-1 adrenergic receptor agonist is commonly used by optometrists, ophtha"...
Alcaine Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Alcaine (proparacaine hydrochloride 0.5%) is a topical anesthetic for the eyes used during eye surgeries and procedures. It is available in generic form. Common side effects of Alcaine include eye irritation and stinging.
The recommended dosage of Alcaine is 1 or 2 drops prior to having surgery or procedure and 1 drop every 5 or 10 minutes for 5 to 7 doses for cataract extraction. Alcaine may interact with other drugs. Tell your doctor all medications you use. Rinse your eyes with sterile distilled water before using Alcaine. Avoid rubbing or touching your eyes until Alcaine has worn off. If you are pregnant only use Alcaine if clearly needed. Exercise caution if you use Alcaine and are breastfeeding.
Our Alcaine (proparacaine hydrochloride 0.5%) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Alcaine FDA Prescribing Information: Side Effects
Pupillary dilatation or cycloplegic effects have rarely been observed with proparacaine hydrochloride. The drug appears to be safe for use in patients sensitive to other local anesthetics, but local or systemic sensitivity occasionally occurs. Instillation of proparacaine in the eye at recommended concentration and dosage usually produces little or no initial irritation, stinging, burning, conjunctival redness, lacrimation or increased winking. However, some local irritation and stinging may occur several hours after the instillation. Rarely, a severe immediate-type, apparently hyperallergic corneal reaction may occur which includes acute, intense and diffuse epithelial keratitis; a gray, ground-glass appearance; sloughing of large areas of necrotic epithelium; corneal filaments and, sometimes, iritis with descemetitis. Allergic contact dermatitis with drying and fissuring of the fingertips has been reported. Softening and erosion of the corneal epithelium and conjunctival congestion and hemorrhage have been reported.
Read the entire FDA prescribing information for Alcaine (Proparacaine Hydrochloride Ophthalmic Solution) »
Additional Alcaine Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.